SITUATIONAL: Equipment Qualification
When Equipment Qualification Is Skipped: A Pharmaceutical Facility’s Costly Lesson
Equipment qualification programmes exist to confirm that manufacturing and laboratory equipment performs as intended within defined parameters before it is used to produce or test product. When qualification is treated as paperwork rather than a functional verification, the consequences range from batch failures and investigations to FDA Warning Letters and product recalls. This illustrative scenario follows a pharmaceutical intermediates manufacturer that compressed its equipment qualification timeline and the chain of events that followed.
Note: The organisation, individuals, and specific events described in this scenario are fictional and illustrative. The compliance failures, root causes, and corrective actions are based on patterns commonly identified in FDA Warning Letters, 483 observations, and industry incident investigations involving equipment qualification programmes.
Situation Overview
3
Batches Affected
Three production batches of a pharmaceutical intermediate were manufactured using an unqualified tablet press before the gap was identified during an internal audit.
6 Mo
Timeline Compressed
Planned 6-month equipment qualification programme was reduced to 6 weeks to meet a customer delivery commitment. IQ, OQ, and PQ were all compressed or partially omitted.
FDA
483 Observations
A subsequent FDA inspection issued four 483 observations directly related to the equipment qualification programme, including failure to qualify equipment before use and inadequate validation documentation.
Workplace Background
Meridian Synthesis Partners (fictitious) is a mid-size contract pharmaceutical intermediate manufacturer operating under cGMP regulations. The site produces API intermediates for multiple finished dosage form manufacturers who rely on the site’s compliance status for their own regulatory submissions.
Following a multi-year contract win requiring significantly increased production capacity, site management purchased two new tablet compression units and a granulation suite. The equipment was delivered four months ahead of the planned qualification start date due to an earlier-than-expected manufacturing contract start. Site management faced a choice: request a contract start date extension, or compress the equipment qualification programme to meet the agreed-upon production start.
The Decision That Started the Chain
Senior management elected to compress the qualification programme and begin production on the agreed contract date. The engineering team was directed to complete IQ for all three equipment systems in two weeks and deliver OQ protocols for review within three weeks. PQ was to be conducted concurrently with the first production batches rather than before production began. The Quality Unit raised concerns internally; the decision was not reversed.
Incident Timeline
Month 1, Week 1-2: IQ Completed Under Time Pressure
Installation qualification documents are completed for both tablet presses and the granulation unit. The IQ checklist confirms equipment is installed per manufacturer specifications. However, calibration certificates for three critical instruments: the compression force sensors, the granulation endpoint monitor, and the weight verification scale; these are not yet available from the calibration laboratory. The IQ is approved with a note that calibration records will be attached “when received.”
Month 1, Week 3: OQ Protocols Written but Not Fully Executed
Operational qualification protocols are written for all three systems. Due to time pressure, OQ execution focuses on verifying equipment operation at a single set point rather than across the full operating range specified in the protocols. Tablet press OQ tests compression force at one setting rather than the specified three. Granulation OQ does not include the low-end endpoint monitoring test. Both OQ reports are approved with the incomplete test results included but not flagged as protocol deviations.
Month 2: Production Begins Without Completed PQ
Production of pharmaceutical intermediate batches begins. PQ has not been executed, as the plan to run PQ concurrently with the first production batches means that the first batches are effectively the PQ batches. However, they are not documented as qualification batches, are not reviewed against PQ acceptance criteria, and are not held pending PQ completion. They are released to the customer as standard production batches following normal QC testing.
Month 4: OOS Result Triggers Internal Investigation
Batch 4 of the intermediate generates an OOS result for tablet compression uniformity. The laboratory investigation confirms the result. Phase II investigation identifies that the tablet press compression force sensor has been reading inconsistently, a pattern that was not detectable from the single OQ test point. Review of retained samples from the first three batches identifies similar but within-specification variability that was not reviewed in the context of equipment performance.
Month 5: Internal Audit Identifies Qualification Gaps
A planned internal audit of the equipment qualification programme, conducted independently of the OOS investigation, identifies the IQ approval with missing calibration records, the incomplete OQ execution, and the absent PQ. The audit also identifies that the equipment qualification procedure did not require QU approval before production began on a newly qualified system. Three critical findings are opened; all three are linked to batches already released to the customer.
Month 8: FDA Inspection
A routine FDA inspection of the site covers the equipment qualification programme. Investigators review the qualification documentation for the new equipment, identify the same gaps identified in the internal audit (and several additional gaps), and issue a Form 483 with four observations. The CAPA responses are accepted by FDA but the observation record becomes part of the site’s inspection history for future inspections.
What Went Wrong: The Four Critical Failures
Failure 1: IQ approved with missing calibration data
Calibration certificates for critical instruments are a prerequisite for IQ approval, not a subsequent administrative step. An IQ approved without complete calibration documentation is not a complete IQ. The approval of an incomplete IQ document under time pressure set the precedent for the subsequent failures in OQ and PQ.
Failure 2: OQ executed at single test points
The purpose of OQ is to verify that equipment operates correctly across its specified operating range. Testing at a single set point confirms operation at that point only. The compression force sensor inconsistency that caused the Month 4 OOS would have been detectable if the OQ had been executed across the full compression force range as written in the protocol. Approving an OQ report with incomplete test execution without documenting protocol deviations is a data integrity failure.
Failure 3: PQ not completed before production
Performance qualification confirms that equipment consistently performs within defined parameters under actual production conditions. Running PQ “concurrently” with production without formally designating and documenting those batches as PQ batches, without applying PQ acceptance criteria before release, and without holding release pending PQ completion, means no PQ was conducted. Three released batches were effectively unqualified production batches.
Failure 4: No QU stop before production on unqualified equipment
The equipment qualification SOP did not explicitly require QU approval of a completed qualification package before production could begin on newly installed equipment. This procedural gap allowed production to proceed without a formal QU gate at the most critical control point: the transition from qualification to production status. One additional line in the procedure would have required a QU sign-off that the qualification was complete.
Investigation Findings
Finding
Root Category
Patient/Quality Risk
IQ approved without calibration certificates
Procedural; management pressure
Moderate: uncalibrated instruments used in qualification testing
OQ executed at single test points; incomplete results approved
Procedural; data integrity
High: equipment performance outside tested range not characterised
PQ not completed before production batches released
Systemic; procedural gap
High: unqualified equipment used to produce released product
No QU gate before production on new equipment
Systemic; procedural gap
Moderate: systemic control absent from qualification programme
Root Cause Analysis
Contributing Root Causes
Management decision to compress timeline without risk assessment
Primary
The decision to compress a 6-month qualification programme to 6 weeks was made without a formal risk assessment documenting what qualification activities could be safely accelerated and which could not. Commercial pressure was applied without quality input at the decision level.
Qualification SOP lacked a QU production-start gate
Contributing
The equipment qualification SOP described IQ, OQ, and PQ requirements but did not include a mandatory QU review and approval of the complete qualification package before production could begin. This procedural gap allowed production to start without a formal quality gate.
Approval of incomplete qualification documents without deviation
Contributing
Approvers who signed the IQ and OQ documents approved incomplete packages without opening protocol deviation records. In an environment where management was applying schedule pressure, the path of least resistance was to approve rather than formally document the deviation and delay approval.
Quality culture that elevated schedule over compliance
Systemic
The QU raised concerns at the decision point and was overruled. In a site with a strong quality culture, a QU objection to beginning production on unqualified equipment would have been treated as a stop decision, not an input to be overridden. The willingness to override QU concerns is the deepest systemic root cause.
Corrective Actions Implemented
1
Complete qualification of all three equipment systems
Full IQ, OQ, and PQ executed for all systems against the original protocols. Missing calibration certificates obtained and formally incorporated into the IQ records. OQ re-executed across the full operating ranges specified in the protocols. PQ conducted and completed with formal acceptance criteria review before any further production batches were released.
2
Revise equipment qualification SOP to add QU production-start gate
The equipment qualification SOP was revised to require formal QU review and written approval of the complete qualification package (IQ, OQ, PQ) before any production activity could begin on newly installed or significantly modified equipment. The QU approval is a prerequisite in the batch manufacturing record system; production cannot be initiated without it.
3
Retrospective risk assessment of released batches
A retrospective risk assessment of the three released batches was conducted using available testing data, process parameters, and retained sample re-testing results. The assessment concluded that the batches met specification requirements but had been produced on equipment whose performance range had not been fully characterised. Customers were notified of the qualification gap and provided with the retrospective assessment.
Lessons Learned
Qualification timelines are not negotiable without formal risk management
When commercial or schedule pressure creates a situation where a full qualification programme cannot be completed before production must begin, the decision to proceed requires a formal risk assessment that identifies which activities are being accelerated, what residual risk that creates, and what additional controls or restrictions will apply to batches produced during the qualification period. An informal management decision to proceed is not a risk management process.
Incomplete qualification documents must be documented as deviations, not quietly approved
When an IQ, OQ, or PQ protocol cannot be executed as written, the deviation from protocol must be formally documented, assessed, and resolved before the qualification can be considered complete. Approving a qualification document that includes incomplete test execution without a deviation record is a data integrity failure and a misrepresentation of the qualification status. The qualification is either complete as written, or it has a documented deviation with an assessed impact.
A QU objection to a compliance shortcut is a stop signal, not a risk input
The most consequential decision in this scenario was made when management overrode the QU’s concern about beginning production on unqualified equipment. In a compliant pharmaceutical quality system, the QU has the authority and the obligation to prevent production on unqualified equipment. When that authority is overridden by commercial pressure, the quality system’s most important control is removed. Building that control into the qualification procedure as a non-negotiable prerequisite is what transforms a cultural expectation into an enforceable operational requirement.
Prevention Checklist: Equipment Qualification Programme
Before Qualification Begins
Qualification plan approved by QU before equipment installation begins
All calibration standards and references available before IQ begins
Protocol completion requirements documented before testing begins
Acceptable timeline confirmed and signed off by QU
During Qualification
All protocol test steps executed across full specified ranges
Any deviation from protocol documented and assessed before document approval
IQ, OQ, and PQ each fully completed before moving to the next phase
PQ conducted and accepted before any production batch is released
Before Production Begins
Complete qualification package reviewed and approved by QU
QU approval formally documented as prerequisite for production start
Equipment status updated to qualified and labelled accordingly
Qualification documentation filed and retrievable for inspection
Frequently Asked Questions
What is the difference between IQ, OQ, and PQ in equipment qualification?
IQ (Installation Qualification) confirms equipment is installed correctly per manufacturer specifications and site requirements, including utility connections, instrument calibration, and documentation. OQ (Operational Qualification) confirms equipment operates correctly across its full specified operating range according to approved SOPs. PQ (Performance Qualification) confirms equipment consistently performs within defined parameters under actual production conditions using production materials and processes. Each phase builds on the previous one and must be fully completed and approved before the next begins. Incomplete execution of any phase means the qualification for that phase is not complete, regardless of whether the document has been signed.
Can production batches manufactured during PQ be released to customers?
This depends on how the facility’s qualification programme and regulatory strategy are structured. If batches produced during PQ are formally designated as PQ batches with defined acceptance criteria, those criteria must be met before the batches can be considered for release. A batch produced while PQ is ongoing but not formally treated as a PQ batch, without PQ acceptance criteria applied, cannot be used to satisfy the PQ requirement. In either case, production batches should not be released before PQ is complete and approved unless the facility has a formal regulatory strategy addressing this scenario.
What should a facility do if it discovers that equipment was used before qualification was complete?
Stop production immediately and initiate a formal investigation and deviation record. Conduct a retrospective risk assessment of affected batches. Notify customers if product quality may be impacted. Complete the qualification, document corrective actions, and consider self-disclosure depending on the severity and regulatory framework.
Government and Regulatory Sources
Related VelSafe Articles
Building a Qualification Programme That Holds Under Pressure
The fundamental lesson from this scenario is not that the facility lacked knowledge of equipment qualification requirements. It knew what was required. The failure was in the decision to begin production without meeting those requirements under commercial pressure, and in a quality system that did not have the procedural controls to prevent that decision from taking effect. Adding a QU production-start gate to the qualification SOP would not have prevented the commercial pressure. It would have prevented the pressure from overriding the qualification requirement. The distance between a culture where QU concerns are overridden and one where they are enforced is exactly one SOP line and the management commitment to enforce it. Find more pharmaceutical compliance resources at velsafe.com.
